US Stock MarketDetailed Quotes

AFMD Affimed NV

Watchlist
  • 1.3500
  • +0.1600+13.45%
Close Jan 2 16:00 ET
  • 1.3301
  • -0.0199-1.47%
Post 19:52 ET
22.13MMarket Cap-0.29P/E (TTM)

About Affimed NV Company

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

Company Profile

SymbolAFMD
Company NameAffimed NV
Listing DateSep 12, 2014
Issue Price7.00
Founded2000
CEODr. Andreas Harstrick, M.D.
MarketNASDAQ
Employees78
Fiscal Year Ends12-31
AddressGottlieb-Daimler-Strasse 2
CityMannheim
ProvinceBaden Wuerttemberg
CountryGermany
Zip Code68165
Phone49-621-560-030

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andreas Harstrick, M.D.
  • Chief Medical Officer and Interim Chief Executive Officer
  • 1.14M
  • Harry Welten
  • Consulting Chief Financial Officer
  • 88.00K
  • Dr. Wolfgang Fischer
  • Chief Operating Officer
  • 1.26M
  • Denise Mueller
  • Chief Business Officer; Co-President Affimed Inc.
  • 1.17M
  • Dr. Thomas O. Hecht
  • Chairman of the Supervisory Board
  • 162.00K
  • Dr. Bernhard R.M. Ehmer
  • Member of the Supervisory Board
  • 78.00K
  • Dr. Annalisa Mary Jenkins, F.R.C.P.,M.B.B.S.
  • Member of the Supervisory Board
  • 96.00K
  • Dr. Constanze Ulmer-Eilfort
  • Member of the Supervisory Board
  • 39.00K
  • Uta Kemmerich-Keil
  • Member of the Supervisory Board
  • 139.00K
  • Dr. Mathieu Simon
  • Member of the Supervisory Board
  • 75.00K
  • Dr. Ulrich M. Grau
  • Member of the Supervisory Board
  • 85.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.